EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
-16.98%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$4.68B
AUM Growth
+$4.68B
(-27%)
Cap. Flow
-$456M
Cap. Flow
% of AUM
-9.75%
Top 10 Holdings %
Top 10 Hldgs %
25.31%
Holding
151
New
16
Increased
23
Reduced
54
Closed
13
Top Buys
| 1 |
Doximity
DOCS
|
$52.7M |
| 2 |
CMS Energy
CMS
|
$19.4M |
| 3 |
Cheniere Energy
LNG
|
$15.3M |
| 4 |
GTM
ZoomInfo Technologies
GTM
|
$14.9M |
| 5 |
Guardant Health
GH
|
$14.8M |
Top Sells
| 1 |
Dynatrace
DT
|
$112M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$73.7M |
| 3 |
SMAR
Smartsheet Inc.
SMAR
|
$38.2M |
| 4 |
argenx
ARGX
|
$35.3M |
| 5 |
Roper Technologies
ROP
|
$29.9M |
Sector Composition
| 1 | Healthcare | 35.3% |
| 2 | Technology | 26.13% |
| 3 | Industrials | 16.22% |
| 4 | Consumer Discretionary | 5.49% |
| 5 | Utilities | 5.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Design Therapeutics
DSGN
$315M
| $3.94M | 0.08% | 281,569 -118,431 | -30% | -$1.66M |
|
127
Advanced Drainage Systems
WMS
$11.2B
| $3.61M | 0.08% | 40,052 -18,026 | -31% | -$1.62M |
|
128
iRhythm Technologies
IRTC
$5.46B
| $3.17M | 0.07% | +29,300 | New | +$3.17M |
|
129
Phathom Pharmaceuticals
PHAT
$864M
| $2.84M | 0.06% | 336,223 | – | – |
|
130
Silicon Laboratories
SLAB
$4.41B
| $2.68M | 0.06% | 19,137 | – | – |
|
131
Flywire
FLYW
$1.61B
| $2.34M | 0.05% | +132,921 | New | +$2.34M |
|
132
monday.com
MNDY
$9.95B
| $2.11M | 0.05% | 20,409 -12,091 | -37% | -$1.25M |
|
133
Ciena
CIEN
$13.3B
| $1.46M | 0.03% | 32,000 -11,000 | -26% | -$503K |
|
134
Arteris
AIP
$402M
| $1.38M | 0.03% | 198,509 +4,509 | +2% | +$31.4K |
|
135
KB Home
KBH
$4.32B
| $999K | 0.02% | 35,100 -106,600 | -75% | -$3.03M |
|
136
Azenta
AZTA
$1.4B
| – | – | -29,700 | Closed | -$2.46M |
|
137
Bolt Biotherapeutics
BOLT
$9.85M
| – | – | -859,826 | Closed | -$2.36M |
|
138
Cullinan Oncology
CGEM
$445M
| – | – | -1,440,145 | Closed | -$15.1M |
|
139
Cardiff Oncology
CRDF
$140M
| – | – | -1,467,922 | Closed | -$3.64M |
|
140
Shift4
FOUR
$6.21B
| – | – | -70,000 | Closed | -$4.34M |
|
141
nCino
NCNO
$3.72B
| – | – | -416,200 | Closed | -$17.1M |
|
142
Outset Medical
OM
$247M
| – | – | -69,000 | Closed | -$3.13M |
|
143
Syndax Pharmaceuticals
SNDX
$1.41B
| – | – | -1,165,000 | Closed | -$20.2M |
|
144
Xencor
XNCR
$580M
| – | – | -500,755 | Closed | -$13.4M |
|
|
SMAR
145
DELISTED
Smartsheet Inc.
SMAR
| – | – | -697,000 | Closed | -$38.2M |
|
|
IMGN
146
DELISTED
Immunogen Inc
IMGN
| – | – | -1,000,000 | Closed | -$4.76M |
|
|
ETTX
147
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| – | – | -590,602 | Closed | -$1.1M |
|
|
148
Dynatrace
DT
$15.3B
| – | – | -2,386,741 | Closed | -$112M |
|